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Hyperspectral data processing 
improves PpIX contrast during 
fluorescence guided surgery of 
human brain tumors
J. J. Bravo  1, J. D. Olson  1, S. C. Davis1,2, D. W. Roberts1,2,3,4, K. D. Paulsen1,2,3 & S. C. Kanick  1
Fluorescence guided surgery (FGS) using aminolevulinic-acid (ALA) induced protoporphyrin IX (PpIX) 
provides intraoperative visual contrast between normal and malignant tissue during resection of high 
grade gliomas. However, maps of the PpIX biodistribution within the surgical field based on either 
visual perception or the raw fluorescence emissions can be masked by background signals or distorted 
by variations in tissue optical properties. This study evaluates the impact of algorithmic processing 
of hyperspectral imaging acquisitions on the sensitivity and contrast of PpIX maps. Measurements in 
tissue-simulating phantoms showed that (I) spectral fitting enhanced PpIX sensitivity compared with 
visible or integrated fluorescence, (II) confidence-filtering automatically determined the lower limit 
of detection based on the strength of the PpIX spectral signature in the collected emission spectrum 
(0.014–0.041 μg/ml in phantoms), and (III) optical-property corrected PpIX estimates were more highly 
correlated with independent probe measurements (r = 0.98) than with spectral fitting alone (r = 0.91) 
or integrated fluorescence (r = 0.82). Application to in vivo case examples from clinical neurosurgeries 
revealed changes to the localization and contrast of PpIX maps, making concentrations accessible that 
were not visually apparent. Adoption of these methods has the potential to maintain sensitive and 
accurate visualization of PpIX contrast over the course of surgery.
Resection decisions made by neurosurgeons often involve trade-offs between maximizing tumor removal and 
minimizing function deficits secondary to surgery. The current state-of-the-art relies on visual inspection of the 
surgical field, assisted by image-guidance based on preoperative radiologic imaging. Fluorescence guided sur-
gery (FGS) using aminolevulinic acid (ALA) induced protoporphyrin IX (PpIX) is a newer approach that offers 
immediate and concurrent intraoperative imaging for guiding resection decisions1, 2. The procedure involves 
administration of ALA, which is a non-fluorescent pro-drug that leads to a temporarily-enhanced accumula-
tion of the endogenous fluorophore PpIX in malignant tissue. PpIX selectivity is based on a combination of 
pathophysiological hallmarks of cancer, including decreased vascular integrity and altered cellular metabolism3. 
However, standard FGS techniques rely on raw PpIX fluorescence from the surgical field, which may subopti-
mally reflect malignancy for two primary reasons. First, the raw fluorescence emissions contain background 
contributions from other sources (e.g. excitation light leakage, autofluorescence and photoproducts) which may 
alter the lower limit of sensitivity to PpIX4, and affect discrimination of locations having different PpIX accu-
mulations. Second, raw fluorescence intensity is influenced not only by the concentration of PpIX but also by 
tissue optical absorption and scattering at excitation and emission wavelengths, which substantially distort the 
remitted signal5, 6. These distortions may be most critical near the end of surgery, when remaining disease must 
be identified within a surgical cavity. These factors represent important limitations of FGS based solely on using 
raw fluorescence emissions to identify residual tumor near the margins of the planned resection volume and/or as 
surgery approaches areas of critical brain function where resection decisions become more difficult.
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Spectroscopic algorithms have been developed to decouple PpIX emissions from other fluorophores and 
eliminate the distorting effects of background optical properties, thereby quantifying the fluorescence that is 
attributable to the PpIX in tissue. These computations have been applied to localized measurements acquired 
by a fiberoptic probe device7, 8, Fig. 1(a), and yield quantitative PpIX data with significantly improved diagnostic 
accuracy (relative to measures of fluorescence intensity) when compared to gold-standard cytology9. Additional 
studies focused on probe-based measurements in meningiomas10 and low-grade gliomas11, which further demon-
strated the increased sensitivity to PpIX after spectral analysis and the clinically relevant diagnostic potential of 
quantitative PpIX evaluation. Similar spectral analyses have since been applied to wide-field imaging of PpIX flu-
orescence12, Fig. 1(b), yielding analogous quantitative estimates capable of characterizing its spatial distribution 
in tissue providing information not available in the same images of raw fluorescence13. While the clinical potential 
of quantitative fluorescence measurements and wide-field imaging of PpIX has been reported in this series of 
papers7–13, the impact of specific processing steps (including a method for evaluating estimates that approach the 
limits of signal sensitivity) and their relationships to point probe measurement data has not been studied, but is a 
prerequisite to addressing the ultimate clinical value of quantitative PpIX evaluation.
Towards this end, the present study considers a series of processing methods for hyperspectral imaging data 
that (I) estimate the PpIX contribution to collected fluorescence emissions, (II) verify the confidence in the esti-
mate, and (III) correct the estimate for distortions from optical properties. The HIS processing methods are 
validated through comparison to highly sensitive probe measurements in tissue-simulating phantoms contain-
ing clinically-relevant optical properties. Bench-top results show that spectrally-processed estimates of PpIX are 
more accurate and more sensitive than inspection of visual fluorescence images, and provide improved contrast 
compared with displays of integrated fluorescence intensity. Application of the methods to in vivo cases illustrate 
where spectrally processed PpIX maps reveal concentrations that are not accessible otherwise. These findings 
highlight how spectral processing is needed to overcome limitations in system sensitivity and optical property 
based distortions of PpIX fluorescence within the surgical field.
Results
Phantom validation. Figure 2 shows a series of composite images constructed from experimentally meas-
ured tissue-simulating phantoms that span a wide range of PpIX concentrations (0.004–10 μg/ml) and optical 
properties (blood volume fraction (BVF) = [0.5–10]%, lipid volume fraction (LVF) = [0.5–2]%). Each panel 
within the figure presents a different method for evaluating PpIX emissions, and the series highlights how PpIX 
quantification is influenced not only by PpIX concentration, but also by attenuation caused by tissue optical prop-
erties. Figure 2(a,b) show the white-light and fluorescence appearance of each phantom as a composite of images 
recorded by the Zeiss camera. Visual estimation of PpIX quantity is influenced significantly by optical properties 
and is only sensitive to PpIX concentrations between 0.37–1.11 μg/mL depending on their values. Figure 2(c) 
shows integration of the spectrally-resolved PpIX waveband, IFPpIX, overlaid on the white-light compilation 
image (converted to concentration units based on assumed phantom optical properties of 2% BVF, 1.5% LVF). 
Sensitivity and contrast are increased compared to the red channel of the Zeiss image because of a lower noise 
camera and a narrower wavelength detection band (620–650 nm), respectively. Figure 2(d) displays spectrally fit 
Figure 1. (a) Diagram of fiber arrangement on probe tip. White-light fibers used for reflectance are located 
260 μm and 520 μm from the detector. The blue-light (405 nm) fiber used to excite PpIX was also located 260 μm 
from the detector. Red (635 nm) light data was not used for this study. (b) Diagram of the light path through the 
Zeiss OPMI Pentero surgical microscope (Carl Zeiss Surgical GmbH); the surgical microscope was equipped 
with the Blue 400 module which filters the internal broadband xenon light source to excite the surgical field in 
the 400–410 nm wavelength range and displays the resulting emissions in the 620–710 nm wavelength band. The 
hyperspectral imaging system (HIS) was attached to a secondary port on the surgical microscope and a liquid 
crystal tunable filter (LCTF) filtered received light (600–720 nm) generated from the same (Blue 400) excitation.
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estimates of PpIX, SFPpIX, obtained from linear spectral decomposition of image-acquired fluorescence spectra 
and overlaid on the white-light compilation image (also converted to concentration units using the same optical 
property assumptions). Spectrally fitting the data increases PpIX detection sensitivity and resolves PpIX in addi-
tional phantoms within the composite image. The error in the spectrally fit estimates was used to determine the 
PpIX Confidence Ratio (CR), Equation 6, or the confidence that the fitted spectrum contains contribution from 
PpIX emissions. These CR values were used as the overlay transparency function (α) to filter data based on model 
confidence, in Fig. 2(e). The CR filter influences the display of PpIX images near the limits of detection. Poorly-
informed estimates of PpIX which had a 99.99% confidence interval spanning zero, and therefore were not differ-
ent from zero (producing CR ≤ 0), were visually excluded once overlaid (i.e. CR = α = 0). As PpIX concentrations 
decrease from left to right in each row, the CR-filtered image provides clarity about which phantoms containing 
PpIX are distinguishable from the background. Figure 2(f) shows the previous image corrected for optical prop-
erties specific to each phantom in the series, increasing the consistency in the PpIX quantification for changing 
optical properties (i.e. the color consistency in each column of PpIX concentrations in the composite of images).
PpIX sensitivity curves for the spectroscopic probe and HIS are shown in Fig. 3(a,b) for the same set of optical 
phantoms presented in Fig. 2. A linear relationship exists between estimated and known PpIX for both systems 
(black lines represent unity). Figure 3(c) shows the contrast-to-noise ratio (CNR) that is achieved by several spec-
tral processing methods vs. PpIX concentration. Here, detectability is defined as a CNR > 3, which is represented 
by a dashed horizontal line. CNR data displayed in Fig. 3(c) are averaged across all phantom optical properties, 
while values in Table 1 correspond to HIS-based PpIX estimates for phantoms containing 2% BVF and 1.5% 
LVF, which is representative of the optical properties of normal cortex. Inspection of the CNR data reveals the 
effect that spectral processing can have on the lower limit of detection (LLD) for PpIX. Visual fluorescence, taken 
from Zeiss captures, fails to reach a CNR of 3 for any of the PpIX concentrations tested, highlighting the need 
for spectral-based processing methods. Integration of the spectrally-resolved waveband improves contrast, and 
Figure 2. Panels of composite images constructed from experimentally measured phantom data with different 
processing of PpIX emissions. Within each panel, composite images represent 8 PpIX concentrations (left to 
right, see upper legend far right) mixed with increasing blood volume fraction (BVF), constant 1.5% lipid 
volume fraction (LVF), and increasing LVF, constant 2% BVF (top to bottom). The background in each row 
represents a liquid phantom containing no PpIX. Small variations in the color of each phantom are due 
primarily to minute differences in blood concentration. (a) Reflectance image; pixels were sampled from the 
white-light images captured by the built-in Zeiss camera. (b) Visible fluorescence image; pixels were sampled 
from Zeiss fluorescence images. (c) Integrated fluorescence image; integrated fluorescence intensities (IFPpIX) 
were converted to concentration units (see lower legend far right) based on assumed phantom optical properties 
and overlaid onto the reflectance image in (a) using a transparency based on integrated intensity. (d) Spectrally 
fit image; concentration estimates (SFPpIX) based on the same assumed phantom optical properties were overlaid 
onto the reflectance image in (a) using a transparency based on concentration. (e) Confidence ratio filtered 
image; concentration estimates (SFPpIX) were overlaid onto the reflectance image in (a) using a transparency 
based on the confidence ratio (CR). (f) Optical property corrected image; concentration estimates (CPpIX) based 
on optical properties specific to each individual phantom were overlaid onto the reflectance image in (a) using a 
transparency based on the CR.
www.nature.com/scientificreports/
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achieves an LLD of 0.12 μg/mL. Spectral fitting further improves the contrast, decreasing the LLD by an order 
of magnitude to 0.014 μg/mL for most of the optical properties considered. Application of the confidence-based 
filter results in CNR > 3 over the entire range of PpIX concentrations evaluated, including 0.004 μg/mL; although, 
at this limit of detection the CR filter only provides PpIX estimates in a fraction of the pixels contained in the 
phantom image, Table 1. Application of optical-property corrections specific to each individual phantom did not 
affect the CNR, as shown in Table 1 and are not included in Fig. 2(e). CNR for the probe is higher than for all HIS 
methods; generating an LLD close to 0.004 μg/mL due in part to a more accurately described background signal, 
and justifies the use of the probe as a gold-standard in the present study. Figure 3(d–f) compares probe-based 
estimates of CPpIX to various metrics of fluorescence from the HIS, including integrated fluorescence (IFPpIX), 
spectrally fit fluorescence (SFPpIX), and optical property corrected fluorescence (CPpIX), respectively. The data in 
Fig. 3(d–f) were filtered to exclude PpIX concentrations below 0.014 μg/ml (HIS LLD) and a BVF less than 1%, 
to eliminate issues with fluorescence correction factors at low absorption. These results clearly demonstrate that 
accounting for optical property distortions specific to each individual phantom yields a highly linear relationship 
between probe and HIS CPpIX estimates (r = 0.98) with reduced variation in the data (mRPE = 35 ± 35%) relative 
to integrated fluorescence intensity (r = 0.82; mRPE = 281%), or spectral fitting without phantom-specific optical 
property correction (r = 0.91; mRPE = 45%).
Figure 3. PpIX concentration (CPpIX) estimates from (a) spectroscopic probe and (b) HIS over a wide range of 
PpIX concentrations (0.004–10 μg/ml) and optical properties (BVF = [0.5–10]%, LVF = [0.5–2]%), black lines 
represent unity. (c) Contrast-to-noise ratio (CNR) for each system shown as a mean and interquartile range 
at each PpIX concentration, dotted line represents an CNR of 3 (threshold for lower limit of detection, LLD). 
Probe CPpIX compared to HIS estimates of (d) integrated fluorescence (IFPpIX), (e) spectrally fit fluorescence 
(SFPpIX), and (f) optical property corrected fluorescence (CPpIX).
Concentration [μg/mL] 10 3.33 1.11 0.37 0.12 0.041 0.014 0.004
Integrated Fluorescence
Average CNR 344 166 64.8 21.8 6.58 1.83 1.22 0.51
Spectrally Fit
Average CNR 1689 891 344 117 35.0 11.3 4.03 1.46
CR Filtered
Number of pixels 40000 40000 40000 40000 40000 40000 22812 276
Average CNR 1689 891 344 117 35.0 11.3 4.57 3.83
Corrected Fluorescence
Number of pixels 40000 40000 40000 40000 40000 40000 22812 276
Average CNR 1708 878 338 118 36.0 11.3 4.58 3.63
Table 1. Contrast-to-noise ratio (CNR) of HIS-based PpIX concentrations estimated in tissue-simulating 
phantoms representative of normal cortex (2% BVF, 1.5% LVF). CR-filtered estimates show the number of pixels 
in the composite phantom image that returned a PpIX estimate with a confidence that was greater than zero.
www.nature.com/scientificreports/
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PpIX estimates in Fig. 2 indicate that the detection limits of PpIX are influenced by optical properties, par-
ticularly changes in BVF. The LLD obtained by HIS triples when transitioning from 1% to 2% BVF (0.004 μg/ml 
to 0.014 μg/ml) and again when transitioning to 3% BVF (0.041 μg/mL) and to 10% BVF (0.12 μg/mL). CR-based 
filtering has the advantage of not relying on an absolute CPpIX threshold determined through extensive charac-
terization of the imaging system over a large parameter space. By incorporating the CR-filtering step into the 
processing, the LLD for PpIX quantification is determined automatically from the strength of the PpIX spectral 
signature in the collected emission spectrum.
Patient case illustrations. Figure 4 illustrates the effect of spectral image processing on identifying PpIX 
fluorescence in a representative surgical field (atypical meningioma [WHO grade II] towards the end of resec-
tion). Figure 4(a) includes an magnetic resonance (MR) texture map of the surgical field interpolated from the 
coregistered preoperative MR image volume and focal point of the operating microscope tracked in coordinates 
Figure 4. Increased sensitivity to PpIX using wide-field spectroscopic processing is illustrated for a 
representative case of an atypical meningioma (WHO grade II) towards the end of resection. (a) MR-encoded 
texture map interpolation of the intraoperative location given by the focal point of the operating microscope 
and the corresponding views of the surgical field under white- and blue-light illumination acquired with the 
Zeiss Pentero microscope. Log-compressed integrated fluorescence, IFPpIX, is overlaid onto the white-light Zeiss 
image shown in (a), and is analogous to fluorescence observed during FGS. In (b) through (d), the wide-field 
spectroscopic techniques are summarized and a simple visual description presented. (b) The spectral signature 
of PpIX is used to extract its contribution from contaminating background signals to produce a spectrally 
fit PpIX image, SFPpIX. Further processing includes application of (c) a transparency function based on the 
PpIX confidence ratio to the SFPpIX image to filter noise and poor PpIX estimates and (d) an optical property 
correction specific to the tissues in the surgical field to yield a CPpIX map. Resulting maps show the specific PpIX 
biodistribution, which is masked by background fluorescence and specular reflections when using only raw 
integrated fluorescence.
www.nature.com/scientificreports/
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provided by the navigation system. Corresponding white- and blue-light (fluorescence mode) views of the sur-
gical field observed through the operating microscope are also shown. For comparison, an IFPpIX image was 
produced by acquiring a multispectral data set, integrating the raw fluorescence spectra, and overlaying the result 
on a white-light view of the same surgical field. The IFPpIX image is similar to the Zeiss fluorescence image in 
Fig. 4(a) since it is also based on raw fluorescence, and thus serves as a baseline for comparing the spectral pro-
cessing steps outlined in Fig. 4(b–d). First, the spectral signature of PpIX was used to extract its contribution 
from contaminating background signal, and generate the SFPpIX image in Fig. 4(b). One consequence of this 
procedure was suppression of false positives caused by reflections. Errors in the spectral fits determine the PpIX 
CR, Equation 6, and were applied to α to filter data based on model confidence, Fig. 4(c). In this example, the 
confidence filter eliminated signals outside the exposed brain, and outside the tumor region not likely arising 
from PpIX. Thus, the PpIX CR avoids the need to define a concentration threshold by censoring areas with low 
confidence in the PpIX estimates. Additional processing to correct for tissue-specific optical property distortions 
in the measured fluorescence yielded CPpIX maps, Fig. 4(d). Finally, Fig. 5 confirmed that the results generated by 
these image-processing procedures agreed with probe measurements acquired in the same surgical field. In this 
comparison, the location of the probe measurements was determined by co-registering HIS images with Zeiss 
image captures acquired during probe recordings.
Images and point spectra from the start and nearing the end of resection for the patient in Fig. 4 are contrasted 
in Fig. 6 to illustrate the value of CPpIX images filtered by PpIX CR in terms of localization and contrast relative 
to visual fluorescence (IFPpIX) over the course of surgery. At the start of resection, mild fluorescence is reported 
and easily visible to the surgeon, with strong PpIX signal confirmed with both image and probe spectra. The 
discrepancy in reported quantity between the two systems at marker (+) is likely due to blood accumulation in 
the field during image-stack acquisition leading to reduced image signal; however, PpIX CR is not influenced by 
changes in signal magnitude and still confidently detects PpIX. Importantly, towards the end of resection faint 
fluorescence was reported by the surgeon, which is largely masked by a high background signal, likely cortical 
autofluorescence, in the IFPpIX image but readily identified in the CPpIX map, triangle mark in Fig. 6(j), and con-
firmed by the probe spectra.
Figure 7 shows images and point spectra for a patient with an anaplastic oligoastrocytoma (WHO Grade III) 
and for a patient with a meningioma (WHO grade I). In the first case, no MR contrast or visual fluorescence was 
reported and contamination due to reflections off the cortical surface can be seen in Zeiss blue-light capture and 
IFPpIX image, Fig. 7(c,d). Although PpIX fluorescence in tissue shows up as pink/red, reflected excitation light can 
also appear in the fluorescence imaging channel, as illustrated by the bright pink regions and dura in Fig. 7(c) 
which correspond to bright white regions (reflections) in Fig. 7(b). This phenomenon can confound the imaging 
field but spectral processing can filter out contaminated areas, only highlighting areas attributable to PpIX. In 
Figure 5. Image (top plot) and probe (bottom plot) spectra at locations corresponding to the symbols shown in 
the white-light Zeiss image with CR filtered CPpIX overlay (same as CPpIX image in Fig. 4). Probe spectra confirm 
that regions highlighted by the CPpIX overlay (+ and ○) contain PpIX. Probe measurements in transparent 
regions of the CPpIX overlay (Δ and &#x2B20;) confirm the absence of PpIX signal. Ppp = Photoproduct I; 
PII = Photoproduct II, PIII = Photoproduct III, Bkg = Background, Offset = linear offset for background signal.
www.nature.com/scientificreports/
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the second case, MR contrast and faint visual fluorescence was reported in areas of the surgical field, which are 
not easily visualized in the Zeiss blue-light capture or IFPpIX image, Fig. 7(h,i). PpIX CR filtered CPpIX images, 
Fig. 7(e,j), localize areas of PpIX that were corroborated with corresponding probe measurements.
Discussion
The incorporation of wide-field quantification techniques into FGS serves to improve quantitative feedback to 
the surgeon by providing a map of PpIX across the surgical field. This contrasts the purpose of the probe system, 
which is to sample a localized (point) tissue volume that the surgeon has deemed of interest either from preop-
erative imaging or from observations made within the cavity during surgery. While the probe system has proven 
to accurately quantify PpIX at selected point locations, it is impractical to use the probe to quickly map the dis-
tribution of PpIX over large areas of tissue. Imaging allows for mapping the spatial distribution of PpIX with a 
resolution that the probe system could not provide intraoperatively.
The results of the present study show that the choice of spectral processing steps used to analyze HIS-based flu-
orescence measurements can have a profound influence on the resulting PpIX map. Results from tissue-simulating 
phantoms showed that spectral fitting decouples the contribution of PpIX from background signal, that the eval-
uation of the confidence of fitted PpIX estimates removed poorly-informed estimates of PpIX near the system 
detection limit, and a diffuse-reflectance based optical property correction was able to compensate for the distor-
tive effects of blood and scattering. Application of the spectral processing steps to in vivo case examples during 
clinical neurosurgeries revealed changes to the localization and contrast of PpIX maps; changes that were likely 
more representative of the underlying biodistribution of PpIX. Of interest to clinical practice, the data showed 
that visual fluorescence provided very low contrast-to-noise ratios, which demonstrates the small window of 
PpIX concentrations that are easily distinguishable from the background and motivates the incorporation of 
spectral-based analysis into neurosurgical FGS. Notably, a properly trained neurosurgeon may selectively focus 
on suspicious areas of interest and use experience and contextual information from the surgical field to interpret 
PpIX emissions. However, this approach is limited to fluorescence that the surgeon can visually perceive, down to 
0.37 μg/mL under ideal conditions, based on phantoms with less than 2% BVF, and is qualitative, subjective, and 
relies heavily on surgeon experience. Comparatively, spectrally-processed data has reliable detectability that is an 
order of magnitude lower, in the range of 0.014 μg/mL to 0.041 μg/mL, and offers quantitative and objective meas-
ures of PpIX fluorescence. The limiting factor in detecting PpIX using spectral fitting is signal; detection of even 
Figure 6. MR-encoded texture map and standard white- and blue-light views of the surgical field taken 
through the Zeiss Pentero with log-compressed IFPpIX or PpIX CR filtered CPpIX overlays at the start (a–e) and 
near the end of resection (f–j) in a patient undergoing surgery for atypical meningioma (WHO grade II). IFPpIX 
maps (d,i) are not well localized at either time point whereas spectrally-processed CPpIX overlays (e,j) indicate 
focal regions of detectable PpIX concentration even towards the end of resection when visually apparent 
fluorescence has decreased substantially. Comparisons of PpIX spectra (k) from image (top plot) and probe 
(bottom plot) data at the same locations at the start and end of resection [marked by corresponding symbols in 
the image overlays in (e,j)] confirm the presence of high and very low (or no) PpIX concentration observed in 
the CPpIX overlays. Ppp = Photoproduct I; PII = Photoproduct II, PIII = Photoproduct III, Bkg = Background, 
Offset = linear offset for background signal.
www.nature.com/scientificreports/
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lower concentrations is possible if a longer exposure or spatial filtering is used to reduce noise, as the contrast of 
CR filtered pixels remains elevated (CNR > 3) even at the lowest limit of detectable concentrations.
While previous publications have described the methods for spectral fitting and optical property correction 
of HIS measurements of PpIX12, 13, the present study incorporates a novel confidence-ratio technique to filter the 
wide-field maps automatically and without imposing a specific concentration level threshold. In short, the CR 
filter removes regions of uncertainty from PpIX maps by excluding poorly-informed estimates that may occur 
as the system approaches the PpIX detection limits. The filter uses the error in spectral fits (on a pixel-by-pixel 
basis) to determine the lower limit of detectability rather than relying on absolute PpIX concentration cutoffs 
to define bounds on signal sensitivity. Setting a fixed lower limit a priori for the displayed concentration is con-
founding when imaging through an operating microscope because the lower bound of detection varies with lamp 
intensity, focal length, zoom, and external light sources in addition to tissue optical properties. In a continually 
shifting operating room environment, a fixed concentration limit may result in detectable PpIX being removed 
or poorly-informed PpIX estimates being displayed. In Fig. 2 the transition from panel (d) to (e) showcases CR 
filter advantages, yielding a drastic reduction in background signal and removal of PpIX estimates from some 
low concentration phantoms. These results suggest that the CR filter has the potential to reduce false-positives, 
represented by the background in Fig. 2, by removing data with high PpIX uncertainty.
The application of the spectral processing methods to clinical neurosurgical FGS data, as shown in Figs 4, 5, 6 
and 7, illustrates surgical examples where CPpIX images returned by spectral processing offer improved localization 
and contrast relative to current clinical standards and integrated intensity maps. Locations of potential surgical 
significance were highlighted, and the more accurate representation of the biodistribution of PpIX presented 
in the CPpIX image was confirmed with independent optical probe measurements of PpIX concentration. While 
strong agreement is observed in the comparisons noted throughout the clinical case examples, discrepancies in 
the absolute value of CPpIX reported by the probe and HIS can occur for multiple reasons. First, the two optical 
measurement systems sample different tissue volumes. The HIS samples fluorescence emissions at each pixel 
location that are multiply scattered and therefore blurred/mixed with contributions from surrounding locations 
in the tissue. Conversely, the fiber optics of the probe geometrically localize the fluorescence emissions within a 
small volume of tissue located in close proximity to the probe tip. Second, the HIS samples a tissue surface that 
is not flat and will include height- and orientation-based variations in collected fluorescence intensity, while the 
Figure 7. MR-encoded texture map and standard white- and blue-light views of the surgical field through the 
Zeiss Pentero with log-compressed IFPpIX or PpIX CR filtered CPpIX overlays for a patient with an anaplastic 
oligoastrocytoma (WHO Grade III) (a–e) and for a patient with a meningioma (WHO grade I) (f–j). In the 
first case (top row), the MR-encoded texture map shows no contrast enhancement and the surgeon reported 
no visible fluorescence as observed with IFPpIX (d), where bright regions correspond to reflections off of the 
cortical surface, but PpIX is localized in the CPpIX overlay (e). In the second case (bottom row), there is MR 
contrast enhancement near the image center and faint fluorescence is reported. PpIX fluorescence is not well 
localized in the IFPpIX image (i) but clearly marked in the CPpIX image (j). Comparisons of PpIX spectra (k) from 
image (top plot) and probe (bottom plot) data at the same locations in the two cases [marked by corresponding 
symbols in the image overlays in (e,j)] confirm the presence or absence of PpIX observed in the CPpIX overlay. 
Ppp = Photoproduct I; PII = Photoproduct II, PIII = Photoproduct III, Bkg = Background, Offset = linear offset 
for background signal.
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probe is placed in gentle contact with the tissue surface and (as long as good contact is achieved) is unaffected by 
topographic variations. Third, the HIS assembles spectra at each pixel in the imaged field by collecting sequential 
images at different wavelengths, and even though each image is quickly acquired (50 ms for reflectance, 250 ms for 
fluorescence) movement (e.g. from breathing, etc.) is expected introduce some blurring between the origin and 
coregistered location. Fourth, the longer acquisition time of the HIS compared with the probe is susceptible to 
temporal changes occurring in the surgical field during the measurement, including blood accumulation within 
the surgical cavity during acquisition of the HIS image stack, which can mask PpIX fluorescence. The latter effect 
can be mitigated by using red-light (635 nm) excitation of PpIX14. These discrepancies further advocate for a 
concentration-independent threshold filter and demonstrate the value of the CR filter for localizing PpIX.
Availability of accurate and quantitative CPpIX images have the potential to catalyze application of ALA medi-
ated FGS to other brain tumor histologies. Low-grade gliomas are of particular interest; studies have reported a 
lack of visual fluorescence1, 15, 16 even though PpIX has been detected with microscopic17 and spectroscopic9, 11, 18, 19  
techniques. While the presence of PpIX-based contrast in low-grade gliomas has been confirmed, the low con-
centrations of PpIX make visualization with current FGS methods more difficult. The processing techniques eval-
uated here are ultimately limited by the sensitivity of the current HIS to PpIX, but can be easily applied to more 
sensitive systems as they become available.
The study described in this paper focused on the importance of spectral processing of the raw fluorescence 
signals for yielding accurate maps of the PpIX biodistribution; the data reported do not build the link between 
the detected PpIX concentration and the underlying tissue pathology. Determination of diagnostic performance 
requires more substantial cataloging of clinical data, including detailed comparisons with histology for definitive 
confirmation. Previous work has examined the diagnostic performance of our probe system for various tumor 
histologies8–11 and the results in this study provide the tools necessary to conduct analogous investigations with 
our HIS in the future. Additionally, while this study focused on the detection of PpIX, these techniques can be 
applied to other HISs and/or imaging windows for the detection of other fluorescent markers. For example, 
near-infared (NIR) imaging penetrates deeper into tissue due to significantly reduced absorption of blood and 
other tissue fluorophores, low scattering, and minimal tissue autofluorescence20, but requires augmented display 
since NIR light is not directly visible to the human eye.
Methods
Phantom preparation. Liquid phantoms were constructed, as described previously21, to characterize the 
PpIX fluorescence spectral response sampled over a range of background optical properties and fluorophore 
concentrations. The phantom set incorporated variations in blood volume fraction (BVF) of (0.5, 1, 2, 3, 5, 10)% 
with a constant lipid volume fraction (LVF) of 1.5% and PpIX concentrations in the range of (0.004–10) μg/ml, in 
three-fold dilutions. Additionally, phantoms with a fixed BVF of 2% were made with variations in LVF of (0.5, 1, 
2)% for a total of 81 combinations, including baseline phantoms with no PpIX for each combination. Optical data 
were recorded with both the probe and HIS, and consisted of sequences of reflectance measurements acquired 
under white-light illumination and fluorescence measurements obtained under blue-light illumination.
Image processing steps were validated with composite images generated from this phantom set. Phantom 
composite images were made by randomly selecting a sample of 40,000 pixels from each phantom to form a 
200 × 200 pixel square representing each liquid phantom containing PpIX, generating a 9 × 8 grid. Each phan-
tom contained roughly 45,000 usable pixels after removing those saturated by specular reflections or containing 
bubbles. The background for each row was generated by randomly selecting 980,000 pixels from a liquid phantom 
containing no PpIX to form a 2800 × 350 pixel rectangle; resampling filled the background row. These compi-
lation images provided flexibility and control in the design of a phantom that explored a wide range of PpIX 
concentrations and background optical property variations, while avoiding boundary effects associated with het-
erogeneous phantoms containing inclusions. The compilation images provides insight into the effect of spectral 
processing on pixel-by-pixel basis, but provide no information about spatial localization or resolution limits of 
heterogeneities.
Spectroscopic equipment. Optical measurements were acquired with a custom-built fiberoptic probe and 
hyperspectral imaging system (HIS), both described in detail previously7, 12. Briefly, the hand-held probe con-
tained four active fiber optic leads of 200 μm in diameter: a detector fiber [connected to a USB2000+ spectro-
photometer (Ocean Optics, Dunedin, FL)], a blue LED (405 nm) source (LedEngin Inc. Santa Clara, California) 
fiber, and two fibers that lead to a white LED light source (LedEngin Inc. Santa Clara, California), Fig. 1(a). A 
typical measurement sequence consisted of a blue-light measurement, two white-light measurements, and a dark 
measurement taking about 4 seconds to complete. Each measurement uses test exposures to automatically adjust 
exposure time and averages signal over repeated measurements within a 500 ms acquisition period. The HIS 
used in this study was an updated version an earlier device12. It consisted of three main components: a custom 
optical adapter, a liquid crystal tunable filter (LCTF) (Cambridge Research Instruments), and a complementary 
metal-oxide semiconductor (CMOS) camera (PCO.Edge, Cooke Corp.) connected to a computer control system. 
The custom adapter attached the HIS to a side-port of the Zeiss OPMI Pentero surgical microscope (Carl Zeiss 
Surgical GmbH), and spectral response data was acquired through the microscope light path, Fig. 1(b). Excitation 
light was provided by the Zeiss Blue 400 module functioning in its standard mode of clinical operation, and was 
not otherwise altered or adjusted during use in this study (blue-light intensity from the unit was measured to be 
7 mW/cm2). The HIS recorded a fixed number of wavelengths at a fixed integration time of 50 ms for reflectance 
and 250 ms for fluorescence, resulting in reflectance measurements from 440–720 nm (4 nm spacing, 7 seconds) 
and fluorescence measurements from 600–720 nm (3 nm spacing, 12 seconds). The same fluorescence imaging 
setup described here was used for both benchtop and clinical measurements.
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Data analysis. Processing of Fiberoptic Probe Measurements. Raw white-light reflectance spectra measured 
by the probe were calibrated by subtracting the background signal, dividing by integration time, and then nor-
malizing by a ratio of the model-estimated and measured reflectance spectra of an Intralipid reference phantom 
containing 2% LVF. Work by Kim et al.22 details the probe reflectance analysis model, which expresses diffuse 
reflectance intensity in terms of the absorption coefficient (μa), reduced scattering (µ′s ), and source-detector sep-
aration (ρ), such that λ µ λ µ λ ρ= ′R f( ) ( ( ), ( ), )a s . Tissue µ′s  was estimated using a wavelength dependent power 
law23,
µ λ µ λ′ = ′ λ
λ
−( )( ) ( ) , (1)s s o
b
o
where µ λ′( )s o  and b, the scattering slope, are fitted values. Tissue μa was modeled as a linear sum of significant 
chromophores,
µ λ ε λ ε λ= + −C BVF StO StO( ) [ ( ) (1 ) ( )], (2)a ves a
oxyHb
a
deoxyHb
2 2
where BVF is the blood volume fraction, StO2 is the microvascular saturation, and εa
oxyHb and εa
deoxyHb are the 
wavelength-dependent specific absorption coefficients [1/mm] of fully oxygenated and deoxygenated hemoglo-
bin, respectively. Cves is a correction factor to account for the distortive influences that heterogeneous distribu-
tions of blood vessels have on the effective absorption coefficient24. The factor is given by 
µ= − µ−C e r[1 ]/[2 ]ves
r
a
blood
v
( 2 )a
blood
v , where µa
blood is the μa attributable to blood and rv is the effective mean vessel 
radius, which was set to 8 (the size of a red blood cell). Thus, nonlinear spectral fitting, using lsqnonlin, of 
white-light reflectance spectra yielded estimates of μa and µ′s  using four fitted parameters [µ λ′( )s o , b, BVF, and 
StO2]. These properties were used extrapolate the reduced albedo at excitation wavelength ( µ µ µ′ = ′ + ′a /( )x s x a x s x, , , ), 
which can be used to calculate the total diffuse reflectance at excitation (Rt,x)25. Raw fluorescence spectra meas-
ured by the probe were calibrated by subtracting the background signal and dividing by integration time. 
Quantitative fluorescence returned by the probe (FC
probe) was determined as previously described7 from
λ
µ λ
=


 −









F
R
F
R
( )
1
( ) ,
(3)
C
probe a x
t x
meas
m
,
,
where μa,x is the absorption coefficient at the excitation wavelength of 405 nm, and Rm is the calibrated diffuse 
reflectance measured at 635 nm; this work is described extensively elsewhere7, 22. Spectral fitting of the 
probe-based quantitative fluorescence spectrum yields corrected estimates of contributions from each fluoro-
phore [CPpIX
probe, CPP
probe, and CBkg
probe], which are still in [a.u.] due to the use of unitless basis spectra (normalized to a 
peak of 1). The corrected estimates of PpIX (CPpIX) were converted from a.u. to μg/mL by applying a linear scaling 
factor, βPpIX
probe, which was determined by minimizing the error between PpIX estimates and known concentrations 
in a set of reference phantoms with 2% BVF and 1.5% LVF: β=C CPpIX scaled
probe
Ppix
probe
PpIX unscaled
probe
, , . Processing of probe 
spectra in custom MATLAB scripts required roughly 1 second to complete.
Processing of Hyperspectral Imaging Measurements. HIS images were calibrated by dividing by a measurement 
of spectralon (99%) to correct for nonuniform light distribution across the field-of-view. Fluorescence spectra 
sampled by the HIS were analyzed three different ways to yield three different metrics of PpIX: (I) integrated flu-
orescence (IFPpIX), (II) spectrally fit PpIX (SFPpIX), and (III) corrected or quantitative PpIX (CPpIX). Integrated 
fluorescence was calculated as the area under the fluorescence spectrum from 620 nm to 650 nm. Spectral fitting 
isolated characteristic PpIX signatures by linear unmixing; measured spectra were assumed to be a linear combi-
nation of emission profiles from PpIX, PpIX photoproducts, and background signal, returning the parameter set 
[SFPpIX
HIS , SFPP
HIS, and SFBkg
HIS] which are estimates of the fluorescence contribution [a.u.] of PpIX, PpIX photoprod-
ucts, and background, respectively. Here, background is modeled as a linear function of wavelength with positive 
or negative slope, the former accounting for white light bleeding through the source-side filters in the Zeiss Blue 
400 module (which filters the white-light source to create its blue-light exposure when functioning in fluores-
cence imaging mode), which can be larger than the (negatively sloped) tissue autofluorescence. Quantitative PpIX 
was calculated using a correction algorithm to remove distortions from optical properties, which included a 
simple ratio of fluorescence and reflectance bands at excitation and emission. Quantitative fluorescence returned 
by the HIS ( λF ( )C
HIS ) was determined as described previously12
λ
λ
= − .F
F
R R
( ) ( )
( )
,
(4)
C
HIS meas
x m
0 7
where Fmeas(λ) is the measured fluorescence in [counts/ms], Rx represents measured reflectance at the excitation 
band (465–485 nm), and Rm is the measured reflectance at the emission band (625–645 nm). An excitation band 
of 465–485 nm was chosen due to detection side filters in the Pentero microscope, which did not allow for meas-
urement below 450 nm. Raising Rm to a power of −0.7 served to account for scattering attenuation at emission. 
Spectral fitting of FC
HIS returns estimates of corrected fluorescence [CPpIX
HIS , CPP
HIS, CBkg
HIS] [a.u.]. Conversion from 
[a.u.] to [μg/mL] was again done by applying a linear scaling factor, βPpIX
HIS , which was determined from measured 
phantoms. over a wide range of optical properties and PpIX concentrations. Data processing was performed in 
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custom coded MATLAB scripts (2015a, Mathworks, Natick, MA USA), and spectral processing of HIS data 
required about 4 seconds per image (1.5–2 seconds of which is image registration).
Statistical analysis. Model analysis of reflectance and fluorescence spectra used the coefficient of determi-
nation (R2) as the metric for goodness of fit. Model fits that returned R2 values below 0.9 for either reflectance or 
fluorescence were identified as poor fits and excluded from analysis. For the HIS, spectral fitting was performed 
on a pixel-by-pixel basis but results are presented as the arithmetic mean of pixels in a region of approximately 
1 mm in diameter (n = 201 pixels), roughly matching the diameter of the fiberoptic probe tip. Thus, imaging 
parameter estimates are presented as means and standard errors over approximately 201 pixels. To prevent magni-
fication of noise or suppression of data in pixels with reflectance spectra of poor quality, the fluorescence correc-
tion factor in Equation 4 for the HIS was bounded between 0.2 and 10, based on correction factor values observed 
in tested phantoms. To estimate the lower limit of detection (LLD), contrast-to-noise ratio (CNR) was determined 
for each system at each PpIX concentration. CNR was chosen as an indication of both the quality of the signal and 
its contrast, since both are critically important for surgical guidance. CNR was defined as
µ µ
σ
=
−
CNR ,
(5)
target bkg
bkg
where μtarget is the average fluorescence metric (IFPpIX, SFPpIX, or CPpIX) over a 40,000 pixel ROI in the phantom of 
interest, μbkg is the average fluorescence metric in a optical property matched phantom with no PpIX, and σbkg 
is the standard deviation of the fluorescence metric in a optical property matched phantom with no PpIX. For 
visual fluorescence, the intensity of the red channel was normalized by the sum of all three color channels to allow 
for a rudimentary optical property correction that may better represent how a surgeon experienced with PpIX 
perceives the concentration. This step also compresses the information to a single value for each pixel that can be 
used to calculate the CNR.
Following previous work by Amelink et al.26, confidence intervals (CI) were determined for spectrally fit 
parameters in our reflectance and fluorescence analysis algorithms. CIs represent the uncertainty of an estimated 
parameter value, and we used CIs to inform a filter to automatically identify and reject poorly informed estimates 
of PpIX. The PpIX confidence ratio (CR) was defined as
= −CR CI
SF
1 ,
(6)
hw
PpIX
where CIhw is the 99.99% confidence interval half-width for the estimated value of PpIX. A stringent CI was cho-
sen to conservatively map the PpIX biodistribution and ensure that overlays were constructed using only highly 
reliable estimates. Normalizing by the parameter estimate and subtracting from unity returns values over a range 
of 0 to 1. Negative values (i.e. CIhw > SFPpIX) signify that the estimated parameter value is not different from zero. 
For aggregate phantom data, mean relative percentage error (mRPE) was used to quantify differences between 
PpIX fluorescence metrics that were returned by the probe and HIS. Probe estimates were plotted against HIS 
estimates and mRPE was determined from the best fit line through the data passing through the origin. Thus, 
mRPE is defined as the sum of the absolute value of relative errors −( )actual predictedpredicted  divided by the number of 
values, where the predicted value was determined from the best fit line.
In vivo study characteristics. Data analyzed in this study were collected as part of a broader enroll-
ment of surgical patients with a variety of brain tumor histologies following a protocol that was approved by 
the Committee for the Protection of Human Subjects at Dartmouth. Informed consent was obtained from par-
ticipants included in the study. All research procedures involving human participants were approved by the 
Dartmouth Institutional Review Board. An oral dose of ALA (DUSA Pharmaceuticals) was prepared by dissolv-
ing 20 mg/kg in 100 ml of water and was administered approximately 3 hours prior to induction of anesthesia. 
Preoperative high-resolution, contrast-enhanced T1-weighted or T2-weighted MR images were acquired and 
used for image-guided neuronavigation during each case.
Patients were positioned in a 3-point pin fixation. A StealthStation image-guidance system (Medtronic, 
Louisville, CO, USA) provided the neuronavigation following standard practice. Preoperative MR (pMR) data 
were co-registered with the surgical field using scalp fiducials, and a Zeiss OPMI Pentero surgical microscope 
(Carl Zeiss Surgical GmbH) equipped with the BLUE 400 fluorescence imaging module was tracked. Resection 
was carried out following standard microsurgical technique. The surgeon alternated between white and blue 
light-emitting modes to visualize fluorescence during the case. During spectral image acquisition, the surgical 
microscope was set to a zoom of 2.6x and a focus of 300 nm. The surgeon then placed the intraoperative fiberoptic 
probe on several sites of interest in the surgical field, and quantitative PpIX measurements were recorded. During 
each probe measurement site two Zeiss images were taken as part of the sequence, one image was acquired with 
the probe lights on to allow exact visualization of the probe and the other with the lights off to visualize fluores-
cence emissions around the probe tip. The additional images add 2 seconds to the probe sequence. Control data 
were acquired from normal cortex that did not undergo resection during these procedures. Measured sites were 
also assigned a qualitative visible fluorescence score from 0 to 3 as described previously27 (0, no fluorescence; 1 
minimal fluorescence; 2, moderate fluorescence; and 3, high fluorescence). Resection was continued until the 
surgeon judged that no more tissue could be safely removed.
Visualization techniques. Magnetic resonance (MR) texture maps were generated as detailed in ref. 28. 
Briefly, preoperative MR (pMR) images were segmented and intraoperative stereovision (iSV) data were 
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transformed to match the MR coordinate system. The iSV data was then sampled and projected onto the pMR 
segmentation to geometrically match the pMR brain surface. Finally, the projected iSV intensities were replaced 
with interpolated values from the corresponding pMR image to generate the MR-encoded texture maps. A trans-
parency function was used to overlay pseudo-colored fluorescence images on white-light views of the surgical 
field. The transparency was described by α specified at each pixel within in an image, with values ranging from 0 
to 1 (where 1 is opaque and 0 is completely transparent). Transparency maps for IFPpIX and SFPpIX were generated 
by linearly scaling data within an image to a range of 0 to 1 using fixed upper (UB) and lower (LB) bounds (i.e. 
α = (data − LB)/(UB − LB)). Bounds for IFPpIX and SFPpIX were [5432, 109098] and . .[0 01, 4 5], respectively. 
When the PpIX confidence ratio (CR) filter was applied to SFPpIX or CPpIX, the estimated CR values were directly 
used as the α value. By encoding the confidence estimate into the transparency function, the criterion for display 
of PpIX within an image was based on the quality of PpIX estimated at each pixel within the image.
Overlays of HIS data were plotted on the same colorbar and scale. The unified color scale better visualized 
the effect of each processing step on the data. Since IFPpIX and SFPpIX are normally in a.u., optical properties were 
assumed in order to convert the estimates into units of concentration (μg/mL) for direct comparison with CPpIX. 
The PpIX scaling factor, βPpIX, determined for CPpIX was applied to SFPpIX images in order to use the same color 
scale. Overlay generation required less than a second once the imaging data had been processed.
Data availability. The datasets generated and/or analyzed during the current study are available from the 
corresponding author on reasonable request.
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